BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 16098637)

  • 21. Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.
    Oliveira AF; Cardoso SA; Almeida FB; de Oliveira LL; Pitondo-Silva A; Soares SG; Hanna ES
    Microbiol Immunol; 2012 Aug; 56(8):513-22. PubMed ID: 22671942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.
    Gao X; Cai K; Li T; Wang Q; Hou X; Tian R; Liu H; Tu W; Xiao L; Fang L; Luo S; Liu Y; Wang H
    Vaccine; 2011 Sep; 29(38):6656-63. PubMed ID: 21742003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
    Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
    J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2.
    Tsuji T; Shimizu T; Sasaki K; Tsukamoto K; Arimitsu H; Ochi S; Shimizu T; Taniguchi K; Noda M; Neri P; Mori H
    Vaccine; 2008 Apr; 26(17):2092-9. PubMed ID: 18387720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a live oral attaching and effacing Escherichia coli vaccine candidate using Vibrio cholerae CVD 103-HgR as antigen vector.
    Keller R; Hilton TD; Rios H; Boedeker EC; Kaper JB
    Microb Pathog; 2010 Jan; 48(1):1-8. PubMed ID: 19878715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased apoptosis in the ileum and ileal Peyer's patches: a feature after infection with rabbit enteropathogenic Escherichia coli O103.
    Heczko U; Carthy CM; O'Brien BA; Finlay BB
    Infect Immun; 2001 Jul; 69(7):4580-9. PubMed ID: 11402002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
    Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
    BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
    Chinchilla M; Pasetti MF; Medina-Moreno S; Wang JY; Gomez-Duarte OG; Stout R; Levine MM; Galen JE
    Infect Immun; 2007 Aug; 75(8):3769-79. PubMed ID: 17502396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of a novel gene, rpeA, encoding a putative autotransporter adhesin to intestinal colonization by rabbit-specific enteropathogenic Escherichia coli.
    Leyton DL; Adams LM; Kelly M; Sloan J; Tauschek M; Robins-Browne RM; Hartland EL
    Infect Immun; 2007 Sep; 75(9):4664-9. PubMed ID: 17620350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA.
    Tzschaschel BD; Guzmán CA; Timmis KN; de Lorenzo V
    Nat Biotechnol; 1996 Jun; 14(6):765-9. PubMed ID: 9630987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved secretory production of recombinant proteins by random mutagenesis of hlyB, an alpha-hemolysin transporter from Escherichia coli.
    Sugamata Y; Shiba T
    Appl Environ Microbiol; 2005 Feb; 71(2):656-62. PubMed ID: 15691914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of incompatible plasmids to control expression of antigen by Salmonella typhimurium and analysis of immunogenicity in mice.
    Ervin SE; Small PA; Gulig PA
    Microb Pathog; 1993 Aug; 15(2):93-101. PubMed ID: 8255210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
    Isoda R; Simanski SP; Pathangey L; Stone AE; Brown TA
    Vaccine; 2007 Jan; 25(1):117-26. PubMed ID: 16942819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens.
    Sizemore DR; Warner B; Lawrence J; Jones A; Killeen KP
    Vaccine; 2006 May; 24(18):3793-803. PubMed ID: 16135393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.
    Tzschaschel BD; Klee SR; de Lorenzo V; Timmis KN; Guzmán CA
    Microb Pathog; 1996 Oct; 21(4):277-88. PubMed ID: 8905616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS).
    Wieser A; Magistro G; Nörenberg D; Hoffmann C; Schubert S
    Int J Med Microbiol; 2012 Jan; 302(1):10-8. PubMed ID: 22000741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal immunisation with Stx2B-Tir-Stx1B-Zot protein leads to decreased shedding in goats after challenge with Escherichia coli O157:H7.
    Zhang XH; He KW; Zhao PD; Ye Q; Luan XT; Yu ZY; Wen LB; Ni YX; Li B; Wang XM; Guo RL; Zhou JM; Mao AH
    Vet Rec; 2012 Feb; 170(7):178. PubMed ID: 22186381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
    Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.
    Turner AK; Terry TD; Sack DA; Londoño-Arcila P; Darsley MJ
    Infect Immun; 2001 Aug; 69(8):4969-79. PubMed ID: 11447175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.